Found 5 matching trials
CD40L Antagonism in Rheumatoid Arthritis (RA) PHASE2 The primary objective is to determine if the addition of a 12-week course o...
Show More Location
University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity PHASE3 Primary Objective:
To evaluate the effect of dazodalibep on systemic manif...
Show More Status
Active Not Recruiting
Location
Arizona Arthritis & Rheumatology Associates - Avondale
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis PHASE2 The purpose of the study is to evaluate the efficacy, safety, and pharmacok...
Show More Learn More & Join Trial
VIBRANT: VIB4920 for Active Lupus Nephritis PHASE2 This is a multi-center double-blind placebo controlled clinical trial evalu...
Show More Location
University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology
Learn More & Join Trial
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State PHASE3 Primary Objective:
To evaluate the effect of dazodalibep on patient-report...
Show More Status
Active Not Recruiting
Location
Arizona Arthritis & Rheumatology Associates - Avondale
Learn More & Join Trial